Literature DB >> 4413132

Effects of epinephrine on the pacemaker potassium current of cardiac Purkinje fibers.

R W Tsien.   

Abstract

Epinephrine promotes spontaneous activity in cardiac Purkinje fibers through its action on the pacemaker potassium current (i(KK2)). The mechanism of the acceleratory effect was studied by means of a voltage clamp technique. The results showed that the hormone speeds the deactivation of i(KK2) during pacemaker activity by displacing the kinetic parameters of i(KK2) toward less negative potentials. This depolarizing voltage shift is the sole explanation of the acceleratory effect since epinephrine did not alter the rectifier properties of i(KK2), or the underlying inward leakage current, or the threshold for i(NNa). The dose dependence of the voltage shift in the i(KK2) activation curve was similar in 1.8 and 5.4 mM [Ca](o). The maximal voltage shift (usually approximately 20 mV) was produced by epinephrine concentrations of > 10(-6) M. The half-maximal effect was evoked by 60 nM epinephrine, nearly an order of magnitude lower than required for half-maximal effect on the secondary inward current (Carmeliet and Vereecke, 1969). The beta-blocker propranolol (10(-6) M) prevented the effect of epinephrine (10(-7)M) but by itself gave no voltage shift. Epinephrine shifted the activation rate coefficient alpha(8) to a greater extent than the deactivation rate coefficient beta(8), and often steepened the voltage dependence of the steady-state activation curve. These deviations from simple voltage shift behavior were discussed in terms of possible mechanisms of epinephrine's action on the i(KK2) channel.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4413132      PMCID: PMC2226174          DOI: 10.1085/jgp.64.3.293

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  31 in total

1.  The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

2.  Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-09-28       Impact factor: 5.182

3.  Cyclic AMP mediates the effects of adrenaline on cardiac purkinje fibres.

Authors:  R W Tsien; W Giles; P Greengard
Journal:  Nat New Biol       Date:  1972-12-06

4.  Separation of the pace-maker and plateau components of delayed rectification in cardiac Purkinje fibres.

Authors:  O Hauswirth; D Noble; R W Tsien
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

5.  Slow inward current and action potential in cardiac Purkinje fibres. The effect of Mn plus,plus-ions.

Authors:  M Vitek; W Trautwein
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

6.  Electrogenic suppression of automaticity in sheep and dog purkinje fibers.

Authors:  M Vassalle
Journal:  Circ Res       Date:  1970-09       Impact factor: 17.367

7.  Heterogeneity of excitable membrane: electrophysiological and pharmacological evidence and some consequences.

Authors:  H Grundfest
Journal:  Ann N Y Acad Sci       Date:  1966-07-14       Impact factor: 5.691

8.  Electrophysiological effects of isoproterenol on Purkinje fibers of the heart.

Authors:  D G Kassebaum; A R Van Dyke
Journal:  Circ Res       Date:  1966-11       Impact factor: 17.367

9.  Adrenaline: mechanism of action on the pacemaker potential in cardiac Purkinje fibers.

Authors:  O Hauswirth; D Noble; R W Tsien
Journal:  Science       Date:  1968-11-22       Impact factor: 47.728

10.  Mode of action of chronotropic agents in cardiac Purkinje fibers. Does epinephrine act by directly modifying the external surface charge?

Authors:  R W Tsien
Journal:  J Gen Physiol       Date:  1974-09       Impact factor: 4.086

View more
  55 in total

1.  Proceedings: Functional hyperaemia in soleus muscle of the cat.

Authors:  T Forrester; I J Hamilton
Journal:  J Physiol       Date:  1975-07       Impact factor: 5.182

2.  Reconstruction of the electrical activity of cardiac Purkinje fibres.

Authors:  R E McAllister; D Noble; R W Tsien
Journal:  J Physiol       Date:  1975-09       Impact factor: 5.182

3.  The relation between the current underlying pacemaker activity and beta-adrenoceptors in cardiac Purkinje fibres: a study using adrenaline, procaine, atenolol and penbutolol.

Authors:  K Hashimoto; O Hauswirth; H D Wehner; R Ziskoven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

4.  Acetylcholine inhibits activation of the cardiac hyperpolarizing-activated current, if.

Authors:  D DiFrancesco; C Tromba
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

5.  Characteristics of the rectifying properties of the sino-atrial node cell of the rabbit.

Authors:  I Seyama
Journal:  J Physiol       Date:  1976-02       Impact factor: 5.182

6.  Effects of protein kinase inhibitors on canine Purkinje fibre pacemaker depolarization and the pacemaker current i(f).

Authors:  F Chang; I S Cohen; D DiFrancesco; M R Rosen; C Tromba
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

7.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

8.  Physiological role of endogenous amines in the modulation of ventricular automaticity in the guinea-pig.

Authors:  J Hume; B G Katzung
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

9.  Epinephrine and the pacemaking mechanism at plateau potentials in sheep cardiac Purkinje fibers.

Authors:  A J Pappano; E E Carmeliet
Journal:  Pflugers Arch       Date:  1979-10       Impact factor: 3.657

10.  Pace-maker current changes during intracellular pH transients in sheep cardiac Purkinje fibres.

Authors:  P P Van Bogaert
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.